PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23513474-6	2012	Treatment of RL95-2 cells with E, daidzein or genistein significantly increased the FasL expression by 7-10 folds.	Genistein	46-55	Fas ligand	Homo sapiens	84-88	
19994890-10	2010	Western blot data revealed that genistein (6) stimulated an increase in the protein expression of Fas, FasL, and p53.	Genistein	32-41	Fas ligand	Homo sapiens	103-107	
24299158-7	2014	Significant reduction of PI3K and AKT protein and significant increase of Fas ligand, Fas-associated protein with death domain, cytochrome C, truncated Bid, caspase-9, and caspase-3 were all noted after genistein, resveratrol, and quercetin treatment.	Genistein	203-212	Fas ligand	Homo sapiens	74-84	
19813266-10	2010	Genistein triggered the receptor-mediated apoptotic pathway through upregulation of TNF-alpha, FasL, TRADD, and FADD and activation of caspase-8.	Genistein	0-9	Fas ligand	Homo sapiens	95-99	
9247148-3	1997	Cyclosporin A interfered with CD95L expression, Ascorbic Acid and Glutathione inhibited cell death triggered by CD95/CD95L interaction; Genistein and PNU152518 acted on both steps.	Genistein	136-145	Fas ligand	Homo sapiens	30-35	
9247148-3	1997	Cyclosporin A interfered with CD95L expression, Ascorbic Acid and Glutathione inhibited cell death triggered by CD95/CD95L interaction; Genistein and PNU152518 acted on both steps.	Genistein	136-145	Fas ligand	Homo sapiens	117-122